Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Cyclin A2 Monoclonal Antibody (6B4D11)

Mouse Monoclonal Antibody

Supplier:  Invitrogen™ MA1180

Catalog No. PIMA1180


Only null left
Edge
Add to Cart

Description

Description

MA1-180 detects CCNA2 from human and mouse samples. MA1-180 has been successfully used in western blot and immunofluorescence applications.

Cyclins are regulatory subunits of the cyclin-dependent kinases (cdks) and they control transition at different specific phases of the cell cycle. The temporal expression of cyclins is tightly regulated and subsequently plays a critical role in controlling the enzymatic activity of cdks. These cyclin / cdk complexes are essential for passage through specific stages in the cell cycle. In mammalian somatic cells, cyclin A is required for S phase and passage through G2-phase.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

Cyclin A2
Monoclonal
1 mg/mL
PBS with 1mg/mL BSA, 30% glycerol and 0.05% sodium azide; pH 7.4
P20248, P51943
CCNA2
Human CCNA2 expressed in E. Coli.
100 μg
Primary
Human, Mouse
Antibody
IgG1
Western Blot, Immunocytochemistry
6B4D11
Unconjugated
CCNA2
AA408589; Ccn1; Ccn-1; CCNA; CCNA2; ccna2.S; Cyca; CycA2; Cyclin A; cyclin A2; Cyclin A2 (Cyclin A); cyclin A2 S homeolog; Cyclin A-3; cyclin-A; Cyclin-A2; XELAEV_18009326mg
Mouse
Protein A
RUO
12428, 890
-20°C, Avoid Freeze/Thaw Cycles
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.